Evidence map›Paper›PMID 22509786›Full record

ArticleJournal of the American Chemical Society2012

Pharmacokinetics of Py-Im polyamides depend on architecture: cyclic versus linear.

Jevgenij A Raskatov, Amanda E Hargrove, Alex Y So, Peter B Dervan

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Antitumor activity of a pyrrole-imidazole polyamide.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  13. Synthesis of cyclic Py-Im polyamide libraries.The Journal of organic chemistry · 2013
    Article
  14. Article
  15. Review
  16. Article
  17. Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jevgenij A RaskatovDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Amanda E Hargrove
Alex Y So
Peter B Dervan
California Institute of Technology · US

Funding

SITE SPECIFIC CHEMICAL METHODS FOR CLEAVING GENOMIC DNAR01GM051747 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1995 to 2014
$6.2M
The role of miR-155 in cell cycle regulation and tumorigenesisF32CA139883 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI SO, ALEX STEVEN · 2009 to 2012
$152k
DNA-binding polyamides as Hedgehog inhibitors in human carcinomaF32CA156833 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HARGROVE, AMANDA E · 2011 to 2012
$97k
NCI NIH HHS 1F32CA156833NCI NIH HHS 5F32CA139883NCI NIH HHS F32 CA139883NCI NIH HHS F32 CA156833NIGMS NIH HHS GM051747NIGMS NIH HHS R01 GM051747
6 · The paper itself

Abstract

The pharmacokinetic properties of three pyrrole-imidazole (Py-Im) polyamides of similar size and Py-Im content but different shape were studied in the mouse. Remarkably, hairpin and cyclic oligomers programmed for the same DNA sequence 5'-WGGWWW-3' displayed distinct pharmacokinetic properties. Furthermore, the hairpin 1 and cycle 2 exhibited vastly different animal toxicities. These data provide a foundation for design of DNA binding Py-Im polyamides to be tested in vivo.

Indexed as

AnimalsBody WeightImidazolesMiceMice, Inbred C57BLNylonsPyrrolesImidazolesNylonsPyrroles

Identifiers

PMID22509786
PMCPMC3349014
OpenAlexW1974433420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.